Business description
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen.
Management board & Supervisory board
| CEO |
| Werner Baumann |
| Management board |
| Wolfgang Nickl, Heiko Schipper, Rodrigo Santos, Sarena Lin, Stefan Oelrich |
| Supervisory board |
| Prof. Dr. Norbert Winkeljohann, Oliver Zühlke, Alberto Weisser, André van Broich, Andrea Sacher, Colleen A. Goggins, Dr. Fei-Fei Li, Dr. Norbert W. Bischofberger, Dr. Paul Achleitner, Dr. Simone Bagel-Trah, Dr. Thomas Elsner, Ertharin Cousin, Frank Löllgen, Heike Hausfeld, Horst Baier, Michael Schmidt-Kießling, Petra Reinbold-Knape, Prof. Dr. Otmar D. Wiestler, Reiner Hoffmann, Robert Gundlach |
Company data
| Name: |
Bayer AG |
| Address: |
Kaiser-Wilhelm-Allee 1,D-51368 Leverkusen |
| Phone: |
+49-214-30-1 |
| Fax: |
+49-214-30-81013 |
| E-mail: |
info@bayer.com
|
| Internet: |
www.bayer.de |
| Industry: |
Commodities |
| Sector: |
Chemicals |
| Sub sector: |
- |
| End of financial year: |
12/31 |
| Free Float: |
68.44% |
| IPO date: |
10/1/1953 |
Investor relations
| Name: |
Oliver Maier |
| IR phone: |
+49-214-30-65742 |
| IR Fax: |
+49-214-30-9665742 |
| IR e-mail: |
oliver.maier@bayer.com
|